US › Healthcare

Scynexis Inc (SCYX)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$5.40+6.51%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-21.3M
Profit YoY
-295.1%
EPS
$-3.36
EPS estimate
$-0.99

EPS came in at -3.36 against a street estimate of -0.99 — a miss of 239.4%.

Key statistics

Market cap
$384.5M
Forward P/E
3.7
P/B
1.16
Book value
$5.33
EPS (TTM)
$-3.84
52-week high
$10.48
52-week low
$3.53
50-day MA
$4.45
200-day MA
$5.74
Beta
1.10

Analyst view

Analysts rate Scynexis Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $33.55.

Shareholding

Insiders
2.00%
Institutions
53.31%

Largest institutional holders

FundStake
Squadron Capital Management LLC9.58%
Great Point Partners LLC9.51%
Avidity Partners Management LP5.24%
Heights Capital Management Inc2.63%
Kingdon Capital Management LLC2.50%
Empery Asset Management, LP2.33%
Vanguard Capital Management, LLC1.97%
Dafna Capital Management LLC1.37%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Scynexis Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.